Overview of the PATINA Study

Panelists discuss the PATINA study, examining the role of palbociclib in combination with letrozole as a first-line treatment for hormone receptor–positive, HER2-negative breast cancer, and its impact on progression-free survival.

EP: 1.Overview of the DESTINY-Breast06 Study

EP: 2.Overview of the DESTINY-Breast12 Study

Now Viewing

EP: 3.Overview of the PATINA Study

Recent Videos